Cite

HARVARD Citation

    Zhang, H. et al. (2018). Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update. Expert opinion on pharmacotherapy. pp. 795-807. [Online]. 
  
Back to record